We are live on
!
Find out more
GCM
Gabalex Capital Management Portfolio holdings
AUM
$181M
1-Year Est. Return
9.55%
This Fund
S&P 500
This Quarter
Est. Return
-6.34%
1 Year Est. Return
-9.55%
3 Year Est. Return
+24.9%
5 Year Est. Return
+46.9%
10 Year Est. Return
–
AUM
$257M
AUM Growth
-$21.2M
(-7.6%)
Cap. Flow
-$2.46M
Cap. Flow
% of AUM
-0.96%
Top 10 Holdings %
Top 10 Hldgs %
83.06%
Holding
19
New
4
Increased
3
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$11.6M |
| 2 |
Gilead Sciences
GILD
|
+$11.1M |
| 3 |
Merck
MRK
|
+$9.74M |
| 4 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$8.63M |
| 5 |
NOV
NOV
|
+$6.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$9.56M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$9.12M |
| 3 |
Baxter International
BAX
|
+$8.26M |
| 4 |
Walmart Inc
WMT
|
+$6.88M |
| 5 |
Microsoft
MSFT
|
+$6.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.58% |
| 2 | Consumer Staples | 18.12% |
| 3 | Industrials | 15.06% |
| 4 | Financials | 13.61% |
| 5 | Energy | 11.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
W.W. Grainger
GWW
$66.6B
| $38.7M | 15.06% |
180,000
| – | – |
|
|
2
Walmart Inc
WMT
$920B
| $32.4M | 12.62% |
1,500,000
-300,000
| -17% | -$6.88M |
|
3
Home Depot
HD
$346B
| $31.8M | 12.36% |
275,000
| – | – |
|
4
Berkshire Hathaway Class B
BRK.B
$1.1T
| $19.6M | 7.61% |
150,000
| – | – |
|
5
Booking.com
BKNG
$152B
| $18.6M | 7.22% |
375,000
-125,000
| -25% | -$6.21M |
|
|
6
Microsoft
MSFT
$2.94T
| $15.5M | 6.03% |
350,000
-150,000
| -30% | -$6.74M |
|
7
Wells Fargo
WFC
$264B
| $15.4M | 6% |
300,000
+50,000
| +20% | +$2.75M |
|
8
PepsiCo
PEP
$198B
| $14.1M | 5.51% |
150,000
| – | – |
|
9
SLB Ltd
SLB
$75.9B
| $13.8M | 5.37% |
200,000
+40,000
| +25% | +$3.17M |
|
|
10
Merck
MRK
$333B
| $13.6M | 5.29% |
288,200
+183,400
| +175% | +$9.74M |
|
|
11
ExxonMobil
XOM
$645B
| $11.2M | 4.34% |
+150,000
| New | +$11.6M |
|
|
12
Gilead Sciences
GILD
$168B
| $9.82M | 3.82% |
+100,000
| New | +$11.1M |
|
|
BXLT
13
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $7.88M | 3.07% |
+250,000
| New | +$8.63M |
|
|
14
NOV
NOV
$7.25B
| $5.65M | 2.2% |
+150,000
| New | +$6.14M |
|
|
15
Baxter International
BAX
$12.8B
| $4.93M | 1.92% |
150,000
-218,200
| -59% | -$8.26M |
|
|
POT
16
DELISTED
Potash Corp Of Saskatchewan
POT
| $4.11M | 1.6% |
200,000
-150,000
| -43% | -$3.93M |
|
17
Accenture
ACN
$101B
| – | – |
-50,000
| Closed | -$4.84M |
|
|
KSU
18
DELISTED
Kansas City Southern
KSU
| – | – |
-100,000
| Closed | -$9.12M |
|
|
AET
19
DELISTED
Aetna Inc
AET
| – | – |
-75,000
| Closed | -$9.56M |
|
Similar funds
UIA
HCM
FG
SC
MPU
SFI
JAMH
AEPBI
Gabalex Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Gabalex Capital Management held 19 positions worth $257M, down 7.6% from $278M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Gabalex Capital Management's Q3 2015 filing shows 4 new, 3 increased, 5 reduced and 3 closed positions. Its largest new stake was ExxonMobil: 150,000 shares worth $11.2M. The largest sale was Aetna Inc, an estimated $9.56M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Industrials.
- Gabalex Capital Management's largest Q3 2015 buy was ExxonMobil: 150,000 shares worth $11.2M.
- Gabalex Capital Management added most to Merck in Q3 2015, an estimated $9.74M increase.
- Gabalex Capital Management's biggest Q3 2015 reduction was Baxter International, cutting an estimated $8.26M.
- Gabalex Capital Management fully exited Aetna Inc in Q3 2015, selling an estimated $9.56M.
- Gabalex Capital Management's ten largest holdings make up 83% of its $257M portfolio in Q3 2015.
- Gabalex Capital Management opened 4 new positions and closed 3 in Q3 2015.
- Gabalex Capital Management's portfolio value fell 7.6% quarter-over-quarter to $257M.
Based on Gabalex Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.